oxymatrine has been researched along with wogonin in 2 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (wogonin) | Trials (wogonin) | Recent Studies (post-2010) (wogonin) |
|---|---|---|---|---|---|
| 41 | 0 | 27 | 492 | 0 | 320 |
| 412 | 16 | 270 | 492 | 0 | 320 |
| Protein | Taxonomy | oxymatrine (IC50) | wogonin (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 8.87 | |
| Cyclin-T1 | Homo sapiens (human) | 0.1927 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 2.01 | |
| Cyclin-A2 | Homo sapiens (human) | 1.46 | |
| Cyclin-C | Homo sapiens (human) | 5.9 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.46 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 7.8 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.46 | |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | 5.9 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.192 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 1.07 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Cui, X; Fang, D; Kokudo, N; Tang, W; Wang, Y | 1 |
1 review(s) available for oxymatrine and wogonin
| Article | Year |
|---|---|
Traditional Chinese medicine and related active compounds against hepatitis B virus infection.
Topics: Alkaloids; Antiviral Agents; Artemisinins; Artesunate; Astragalus propinquus; Drugs, Chinese Herbal; Flavanones; Hepatitis B; Hepatitis B virus; Humans; Medicine, Chinese Traditional; Molecular Structure; Phyllanthus; Phytotherapy; Quinolizines; Rheum; Salvia miltiorrhiza | 2010 |
1 other study(ies) available for oxymatrine and wogonin
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |